- Home
- XNCR vs CABO Comparison
XNCR vs CABO Comparison
Compare XNCR & CABO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XNCR
- CABO
- Stock Information
- Founded
- XNCR 1997
- CABO 1980
- Country
- XNCR United States
- CABO United States
- Employees
- XNCR N/A
- CABO N/A
- Industry
- XNCR Biotechnology: Pharmaceutical Preparations
- CABO Cable & Other Pay Television Services
- Sector
- XNCR Health Care
- CABO Telecommunications
- Exchange
- XNCR Nasdaq
- CABO Nasdaq
- Market Cap
- XNCR 1.7B
- CABO 2.0B
- IPO Year
- XNCR 2013
- CABO N/A
- Fundamental
- Price
- XNCR $24.20
- CABO $369.22
- Analyst Decision
- XNCR Strong Buy
- CABO Hold
- Analyst Count
- XNCR 9
- CABO 5
- Target Price
- XNCR $36.33
- CABO $554.40
- AVG Volume (30 Days)
- XNCR 850.2K
- CABO 80.8K
- Earning Date
- XNCR 11-06-2024
- CABO 11-07-2024
- Dividend Yield
- XNCR N/A
- CABO 3.20%
- EPS Growth
- XNCR N/A
- CABO 847.26
- EPS
- XNCR N/A
- CABO 38.05
- Revenue
- XNCR $85,164,000.00
- CABO $1,604,144,000.00
- Revenue This Year
- XNCR N/A
- CABO N/A
- Revenue Next Year
- XNCR $89.22
- CABO N/A
- P/E Ratio
- XNCR N/A
- CABO $9.70
- Revenue Growth
- XNCR N/A
- CABO N/A
- 52 Week Low
- XNCR $15.31
- CABO $311.28
- 52 Week High
- XNCR $27.24
- CABO $574.53
- Technical
- Relative Strength Index (RSI)
- XNCR 44.92
- CABO 41.28
- Support Level
- XNCR $22.74
- CABO $346.85
- Resistance Level
- XNCR $25.54
- CABO $370.92
- Average True Range (ATR)
- XNCR 1.17
- CABO 14.30
- MACD
- XNCR -0.33
- CABO -6.31
- Stochastic Oscillator
- XNCR 22.00
- CABO 27.51
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company based in the United States. It focuses on discovering and developing engineered monoclonal antibody and other protein therapeutics to treat severe and life-threatening diseases such with unmet medical needs. The company uses its XmAb technology platform to create antibody product candidates such as XmAb5871 and XmAb7195. It also has a few pre-clinical stage candidates in its portfolio such as XmAb14045, XmAb662 among others. It earns its revenue from research and development collaborations and licenses of its internally developed drug candidates.
About CABO Cable One Inc.
Cable One Inc is a telecommunications company. It derives revenue from the provision of broadband, voice, and video services to residential and business customers. From a product perspective, the majority of revenue is sourced from data and video services. This revenue is subscription-based and billed monthly. The company also offers Sparklight TV, an internet protocol-based (IPTV) video service that allows customers with Sparklight TV app to stream video channels from the cloud. The company also derives advertising revenue from selling airtime on its video channels. Voice services are offered over Internet protocols. The company owns a telecommunications infrastructure.